Which are the causes of Hypophosphatasia?

Hypophosphatasia (HPP) is a rare, inherited metabolic disorder caused by mutations in the ALPL gene, which encodes the tissue-nonspecific alkaline phosphatase (TNSALP) enzyme. This genetic defect leads to impaired bone mineralization and the accumulation of substrates that prevent healthy bone and tooth development, rather than being triggered by environmental or lifestyle factors.

What causes Hypophosphatasia at the genetic level?

The primary cause of Hypophosphatasia is a mutation in the ALPL gene, located on chromosome 1p36.12. Think of the ALPL gene as an instruction manual for building the TNSALP enzyme. When these instructions are "misspelled" due to a mutation, the body cannot produce enough functional enzyme or produces an enzyme that doesn't work correctly. Without sufficient TNSALP, the body cannot properly mineralize bones and teeth with calcium and phosphorus. This process is like trying to build a brick wall without enough mortar; the "bricks" (bone minerals) are present, but they cannot be held together firmly, leading to the skeletal fragility characteristic of Hypophosphatasia.

Is Hypophosphatasia hereditary?

Yes, Hypophosphatasia is a genetic condition, but the inheritance pattern depends on the specific mutation. It can be inherited in two main ways:

• Autosomal Recessive: This typically causes the more severe, early-onset forms of Hypophosphatasia. A child inherits one mutated gene copy from each parent.


• Autosomal Dominant: This is more common in milder forms, where inheriting a single mutated copy from one parent is sufficient to manifest the disease.

Because it is strictly genetic, Hypophosphatasia is not caused by diet, environmental exposures, or infections. There is no "trigger" that turns the disease on; the genetic blueprint is present from conception.

What is the difference between causes and risk factors in HPP?

In the study of Hypophosphatasia, the distinction is clear: the ALPL mutation is the cause, while the specific type of mutation and the inheritance pattern act as risk factors for disease severity. For example, a patient with two severe recessive mutations will likely experience clinical symptoms in infancy, whereas a patient with a single dominant mutation may not show signs until adulthood. Currently, researchers are investigating why two individuals with the exact same ALPL mutation can sometimes have different clinical outcomes, suggesting that "modifier genes" may play a role in how the body compensates for low TNSALP activity.

What is current research revealing about HPP etiology?

While the genetic basis of Hypophosphatasia is well-understood, medical research is shifting toward how to best replace the missing enzyme activity. Current studies are focusing on:

1. Enzyme Replacement Therapy (ERT): Utilizing bioengineered proteins to supplement the missing TNSALP activity.


2. Genotype-Phenotype Correlations: Mapping thousands of known ALPL mutations to better predict the severity of Hypophosphatasia for newly diagnosed patients.


3. Gene Therapy: Exploring ways to introduce functional copies of the ALPL gene directly into bone-forming cells.

At DiseaseMaps.org, we have seen 9 individuals join our community to share their experiences, helping researchers understand the real-world impact of living with this complex metabolic condition.

Next steps

• Consult with a clinical geneticist to discuss genetic testing and family screening if Hypophosphatasia is suspected.


• Request a referral to a metabolic bone specialist or an endocrinologist experienced in managing rare skeletal disorders.


• Connect with the Hypophosphatasia community at DiseaseMaps.org to share experiences and learn from others living with the condition.


• Visit clinicaltrials.gov to stay informed about active research and potential therapeutic trials.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified physician regarding any medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hypophosphatasia


• Online Mendelian Inheritance in Man (OMIM): ALPL Gene Entry #171760


• Orphanet: Rare Disease Database - Hypophosphatasia


• Soft Bones: The U.S. Hypophosphatasia Foundation